Population Pharmacokinetic of Tacrolimus in Tunisian Renal Transplant Patients: Influence of CYP34A and CYP3A5 Polymorphisms

被引：0
|
作者：
Ben-Fredj, N. [1 ]
Hannachi, I. [1 ,2 ]
Chadli, Z. [1 ]
Kerkeni, E. [1 ]
Ben-Romadhane, H. [1 ]
Ben-Fadhel, N. [1 ]
Hammouda, M. [3 ]
Boughattas, N. A. [1 ]
Chaabane, A. [1 ]
Aouam, K. [1 ]
机构：
[1] Univ Monastir, Fac Med, Pharmacol Lab, Monastir, Tunisia
[2] Carthage Univ, Fac Sci Bizerte, Monastir, Tunisia
[3] Univ Hosp Monastir, Dept Nephrol, Monastir, Tunisia
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS2-024
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
    Zhang, Jing-Jing
    Liu, Shuai-Bing
    Xue, Ling
    Ding, Xiao-Liang
    Zhang, Hua
    Miao, Li-Yan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 728 - 736
  • [32] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [33] Influence of Cyp3a4, Cyp3a5 and Mdr1-C3435t Genetic Polymorphisms in Tacrolimus Pharmacokinetics in Adult Renal Transplant Patients
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Seoane-Pillado, M. T.
    Pedreira-Vazquez, I
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 657 - 658
  • [34] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [35] The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients
    Tirelli, Silvia
    Ferraresso, Mariano
    Ghio, Luclana
    Meregalli, Elisa
    Martina, Valentina
    Belingheri, Mirco
    Mattiello, Camilla
    Torresani, Emilio
    Edefonti, Alberto
    MEDICAL SCIENCE MONITOR, 2008, 14 (05): : CR251 - CR254
  • [36] Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
    Campagne, Olivia
    Mager, Donald E.
    Brazeau, Daniel
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1184 - 1195
  • [37] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S7 - S7
  • [38] Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients
    Ajmi, M.
    Sahtout, W.
    Omezzine, A.
    Amor, D.
    Abderahmene, A.
    Azzabi, A.
    Ben-Rejeb, N.
    Achour, A.
    Bouslama, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
  • [39] Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, Homan J. J.
    Bemelman, F.
    de Fijter, J. W.
    Guchelaar, H. J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 672 - 672
  • [40] The influence of genetic CYP3A5 polymorphism on tacrolimus serum concentration in liver transplant patients
    Albsoul-Younes, Abla
    Al-Jabra, Rabia
    Yousef, Almotessem
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1345 - 1345
12345